Serratia marcescens infections and outbreaks in neonatal intensive care units

Journal of Chemotherapy
A DessìV Fanos

Abstract

Serratia marcescens is an important cause of hospital-acquired infections, especially in neonatal intensive care units (NICUs). This review analyzes clinical signs, risk factors, biotyping and sources of infection in newborns exhibited by this bacteria as well as the therapy which is commonly used and management. This review examines the reported cases of outbreaks of S. marcescens in NICUs published in pubmed over the last 10 years (key words: Serratia marcescens infections, outbreaks, Neonatal intensive Care Units). This report highlights the different prevention and control strategies employed in order to eradicate Serratia outbreaks in NICUs, including all healthcare procedures such as hand washing, introduction of alcohol-based antiseptic gel, enhanced cleaning and disinfection of medical equipment and wards, use of single-patient medical instruments, cohorting of colonized and infected infants, periodic screening cultures, earliest discharge of the infants.

References

Apr 19, 1979·The New England Journal of Medicine·V L Yu
Oct 1, 1992·The Pediatric Infectious Disease Journal·J R CampbellC J Baker
Nov 22, 1997·Journal of Medical Microbiology·A Hejazi, F R Falkiner
Apr 30, 1999·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·V Fanos, L Cataldi
Sep 24, 1999·Drugs·V Fanos, A Dall'Agnola
Apr 27, 2000·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·J Raymond, Y Aujard
Aug 18, 2000·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·P Arivazhagan, C Panneerselvam
Feb 15, 2001·The Journal of Hospital Infection·B L JonesB Thakker
Apr 5, 2001·American Journal of Infection Control·M L ManningW R Jarvis
Jun 29, 2001·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·G A PrasadC R Shivpuri
Jan 5, 2002·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·P VillariA Scarcella
Feb 7, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Felix FleischChristian Ruef
Aug 21, 2002·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Ojan AssadianAlexander M Hirschl
Jul 25, 2003·Advances in Applied Microbiology·J W Bennett, R Bentley
Oct 9, 2003·Journal of Clinical Microbiology·Lin-Hui SuUNKNOWN Infection Control Group
Oct 22, 2003·Archives of Medical Research·Guadalupe Miranda-NovalesFortino Solórzano-Santos
Oct 16, 2004·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Vladana MilisavljevicLisa Saiman
Oct 16, 2004·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Emmi SarvikiviHarri Saxén
Oct 16, 2004·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Kwan Kew LaiSally A Fontecchio
Apr 16, 2005·Journal of Korean Medical Science·Jong Hee HwangSang Il Lee
Mar 7, 2006·The Journal of Hospital Infection·M D DavidA P Fraise
Feb 21, 2007·Journal of Chemotherapy·V FanosM Testa
Apr 17, 2007·American Journal of Infection Control·Petra GastmeierHenning Rüden
Apr 19, 2008·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Lisa L MaragakisTrish M Perl
Aug 30, 2008·The Journal of Hospital Infection·A M Kh Al JaroushaA S Al Afifi

❮ Previous
Next ❯

Citations

Jan 12, 2011·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·G SamonisM E Falagas
Feb 24, 2016·Enfermedades infecciosas y microbiología clínica·Áurea MorilloJavier Aznar
Aug 23, 2011·American Journal of Infection Control·Elias IosifidisEmmanuel Roilides
May 8, 2013·Journal of Veterinary Emergency and Critical Care·Julien Guillaumin, Kate Hopper
Sep 7, 2016·Nefrología : publicación oficial de la Sociedad Española Nefrologia·José L MerinoVicente Paraíso
Dec 15, 2015·PLoS Pathogens·Norberto González-JuarbeCarlos Javier Orihuela
Jul 1, 2017·Arhiv za higijenu rada i toksikologiju·Karmen Godič Torkar, Sanja Ivić
Nov 26, 2014·Infection and Immunity·Norberto González-JuarbeMolly A Bergman
Sep 25, 2012·Annals of Surgery·Erica M CarlisleDonald Liu
Feb 23, 2019·International Journal of Environmental Research and Public Health·Maria Luisa CristinaAnna Maria Spagnolo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
Vladana MilisavljevicLisa Saiman
Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
Lisa L MaragakisTrish M Perl
American Journal of Infection Control
Giovanni Battista OrsiMario Venditti
© 2022 Meta ULC. All rights reserved